Metropolis Healthcare reported numbers and the company has registered a growth of 17 percent for FY19, with margins maintained at 26 percent. Ameera Shah, managing director, said the March 2019 quarter was positive quarter for the company, with revenue growth of about 18.1 percent and EBITDA growth of 16.4 percent.

“We are quite enthused by the buoyant progress that we have seen. Some of this is also because we launched our wellness initiative in Q4 which has given us a bit of increase in numbers,” she added.

Shah said the company’s existing infrastructure, including lab network and spoke network, will support the wellness business. “It is all incremental revenues and should have good operating leverage coming from it. We see this as an additional stream of income to the existing infrastructure,” she added.

“We have expanded our network very aggressively in the last year; 40 percent has been our increase in network expansion and in the last two-and-a-half year we have seen 5.5x increase in network expansion from almost 300 centers to 2,400 centers as of March ’19,” she noted.

On growth front, she said, “The general outlook that we have for the business is extremely positive for FY19-20 and we are quite comfortable with the revenue growth that we have seen.”